Mint Tower Capital Management B.V. Gilead Sciences, Inc. Transaction History

Mint Tower Capital Management B.V.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $311,849 - $447,707	5,004 New	5,004 $430,000
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $17,260 - $21,628	298 New	298 $18,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $2.11 Million - $2.7 Million	-33,650 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $1.59 Million - $1.75 Million	25,751 Added 326.0%	33,650 $2.19 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $290,546 - $320,712	4,648 Added 142.97%	7,899 $501,000
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $196,815 - $256,829	3,251 New	3,251 $203,000
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $282,839 - $313,154	-3,968 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $32,310 - $37,688	498 Added 14.35%	3,968 $281,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $246,890 - $289,814	3,470	3,470 $249,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.